SOLARA Q2 : CONS NET PROFIT TURNAROUND AT RS 28.46 CR (YOY), UP 74.5% (QOQ). GOOD (ON 1ST LOOK)

• Revenue up 33.1% at ₹417.34 Cr (YOY), up 9.4% (QOQ). • Profit before exceptional item and tax at ₹32.96 Cr v loss of ₹10.10 Cr (YOY); H1 profit at ₹44.77 Cr v ₹0.42 Cr. • Exceptional loss of ₹4.50 Cr on sale of capital work in progress of Vizag plant, mothballed since FY24. • Caution: accumulated losses of ₹274.16 Cr as of September 30, 2026; results prepared on going concern basis. • Impact: Q2 net profit turnaround and revenue growth, but accumulated losses and going-concern caution remain key risks.

Solara Active Pharma Sciences Ltd

Open attachment

← Back to feed